148 related articles for article (PubMed ID: 26521450)
1. [The construction of cell-penetrating peptide R8 and pH sensitive cleavable polyethylene glycols co-modified liposomes].
Zhang L; Wang Y; Gao HL; He Q
Yao Xue Xue Bao; 2015 Jun; 50(6):760-6. PubMed ID: 26521450
[TBL] [Abstract][Full Text] [Related]
2. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
[TBL] [Abstract][Full Text] [Related]
3. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
[TBL] [Abstract][Full Text] [Related]
4. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
5. Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides.
Wu M; Huang T; Wang J; Chen P; Mi W; Ying Y; Wang H; Zhao D; Huang S
Medicine (Baltimore); 2018 Aug; 97(33):e11916. PubMed ID: 30113492
[TBL] [Abstract][Full Text] [Related]
6. [Cell penetrating peptide TAT and brain tumor targeting peptide T7 dual modified liposome preparation and in vitro targeting evaluation].
Yuan DF; Zong TL; Gao HL; He Q
Yao Xue Xue Bao; 2015 Jan; 50(1):104-10. PubMed ID: 25924484
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
9. Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides.
Zhang Q; Tang J; Ran R; Liu Y; Zhang Z; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1163-70. PubMed ID: 25693639
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
11. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
12. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
[TBL] [Abstract][Full Text] [Related]
13. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of High Functionality and Quality Cell-penetrating Peptide Conjugated Lipid for Octaarginine Modified PEGylated Liposomes In U251 and U87 Glioma Cells.
El-Gamal FR; Akl MA; Mowafy HA; Mukai H; Kawakami S; Afouna MI
J Pharm Sci; 2022 Jun; 111(6):1719-1727. PubMed ID: 34863974
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Fu H; Hu GL; He Q
Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.
Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE
Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464
[TBL] [Abstract][Full Text] [Related]
17. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.
Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H
Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376
[TBL] [Abstract][Full Text] [Related]
18. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
19. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
